Trials / Completed
CompletedNCT04350489
IL-32 Isoforms Levels in GCF and Plasma of the Patients With Periodontitis
Increased Levels of Interleukin-32 Isoforms Alpha, Beta, Gamma, and Delta in the Gingival Crevicular Fluid and Plasma of the Patients With Periodontitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (actual)
- Sponsor
- Bulent Ecevit University · Academic / Other
- Sex
- All
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Interleukin (IL)-32, which has been recently reported to be associated with periodontitis, has been suggested to have pleiotropic effect due to its 9 different isoforms. The aim of this study was to investigate the levels of IL-32α, IL-32β, IL-32γ, IL-32δ isoforms in gingival crevicular fluid (GCF) and plasma before and after nonsurgical periodontal treatment in patients with periodontitis (P).Twenty-seven P and 27 periodontally healthy controls (C) were recruited in this study. Periodontitis patients were performed nonsurgical periodontal treatment. GCF and plasma sampling and clinical periodontal parameters were evaluated before and 1 month after treatment. Enzyme-linked immunosorbent assay was used to analyze the levels of IL-32α, IL-32β, IL-32γ, IL-32δ isoforms in GCF and plasma samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-surgical periodontal treatment | Conventional non-surgical periodontal treatment were performed |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2020-04-17
- Last updated
- 2020-04-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04350489. Inclusion in this directory is not an endorsement.